Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

The global sales of microbial identification are estimated to be worth USD 4.69 billion in 2025 and anticipated to reach a ...

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...

Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...

ETH Zurich scientists have created “MetaGraph,” a revolutionary DNA search engine that functions like Google for genetic data. By compressing global genomic datasets by a factor of 300, it allows ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

With the Chromatin Immunoprecipitation Testing market projected to double by 2035, the message for manufacturers is clear: ...

Pillar Biosciences, Inc., the leader in Decision Medicine(TM), announced its participation in the 2025 Association for Molecular Pathology (AMP) Annual Meeting in Boston, MA. The company and ...

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

In the study, researchers molecularly screened nearly 2,000 cancer patients and matched 14 percent into a study arm.